| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
FUJIFILM Toyama Chemical Co., Ltd.'s Clinical Stage Antifungal Program (ATI-2307)
Acquired Tokyo, Japan |
Life Science | - | - | - | - |
|
|
Aspen Global, Inc. - Japanese Operations
Acquired Japan |
Life Science | 158 | - | - | - |
|
|
Aculys Pharma
Acquired Minato-ku, Japan website |
Life Science | - | - | - | - |
|
|
Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets
Acquired Osaka, Japan |
Life Science | - | - | - | - |
|
|
QARC
Acquired Japan |
Life Science | - | - | - | - |
|
|
ARCALIS
Acquired Fukushima , Japan website |
Life Science | - | - | - | - |
|
|
Integrated Development Associates Co. Ltd.
Acquired Tokyo, Japan website |
Life Science | - | - | - | - |
|
|
Takeda Pharmaceutical Company - Core Respiratory Business
Acquired Japan |
Life Science | - | - | - | - |
|
|
Santen - Branded Ophthalmic Portfolio
Acquired Osaka, Japan |
Life Science | - | - | - | - |
|
|
Takeda Pharmaceutical Co.,Ltd. - Buccolam
Acquired Osaka, Japan |
Life Science | - | - | - | - |
|
|
Daiichi Sankyo - Eight Branded Products
Acquired Tokyo, Japan |
Life Science | - | - | - | - |
|
|
Craif
Acquired Tokyo, Japan website |
Life Science | - | - | - | - |
|
|
GC Showayakuhin
Acquired Tokyo, Japan website |
Life Science | - | - | - | - |
|
|
Nihon Environmental Services Co., Ltd.
Acquired Tokyo,, Japan website |
Life Science | 23 | - | - | - |
|
|
Teva Takeda Pharma Ltd. - Clinical Packaging Facility
Acquired Minakuchi, Japan |
Life Science | - | - | - | - |
|
|
Nihon Medi-Physics
Acquired Tokyo, Japan website |
Life Science | 183 | - | - | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.